A.L. O'Green

1. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment
   2019/05/24 by V. Deshmukh, A.L. O'Green, Alyssa L. O'Green +37 · 2 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Osteoarthritis Treatment and Mechanisms #Tendon Structure and Treatment #Wnt/β-catenin signaling in development and cancer